Saturday 17 October 2026 Export SNDA’s income statement to Excel — free account

Sonida Senior Living, Inc.

Sonida Senior Living, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $381.1 million, up 25.2% from fiscal 2024. In the quarter to June 2026, revenue grew 122.0%, EPS fell 225.0%, free cash flow fell 291.7% and total debt rose 131.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

35.29 0.58 −1.62%

Follow SNDA

Alert me

Market cap: $1.7B
P/E: 0.0×
Fwd P/E: −11.6×
Dividend yield: —
F-score: 4/9
Altman Z: −0.14
Beneish M: −3.11
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 100.00

Total sells 10.99

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	1	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	1	—	—	3	—	—

Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 1,720.00

Revenue 525.97

Net Income (123.66)

Free Cash Flow (52.71)

Net Debt 1,506.10

Current Ratio 0.88

Debt/Equity 1.81

P/E ratio 0.00

Fwd P/E (11.60)

P/S ratio 3.14

P/B ratio 1.91

Past 5Y EPS Growth —

This Y EPS Growth 14.87%

Next Y EPS Growth 55.88%

Next Y revenue growth 94.55%

Next 5Y EPS Growth 39.17%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 97.24%

10-year low 10-year high

P/B against its own 10 years 4.87%

10-year low 10-year high

EV/Sales against its own 10 years 96.50%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2028	Powerpack
2027	Powerpack
2026	Powerpack
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	18	39	30	65
Receivables	8	19	19	24
Inventory	—	—	—	—
Other	2	1	9	10
	32	64	78	110

	2023	2024	2025	Q'26
Payables	11	9	5	18
ST’ Debt	42	15	7	16
Other	1	0	14	19
	101	76	105	125

Compound Annual Growth %

	10y	5y	3y
Sales	(0.78%)	(0.14%)	16.92%
Cash Flow	(6.73%)	0.00%	0.00%
Earnings	0.00%	0.00%	0.00%
Book Value	(28.11%)	0.00%	0.00%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	123	208	—	—	—
’25	92	94	98	98	381
’24	67	70	75	92	304
’23	62	63	65	66	255
’22	58	60	61	61	238
’21	62	58	58	58	235
’20	106	101	96	80	384

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(36)	9	—	—	—
’25	4	9	12	0	24
’24	(4)	2	3	(3)	(2)
’23	3	2	5	0	11
’22	(1)	(1)	5	(5)	(3)
’21	3	4	(14)	(22)	(29)
’20	(5)	4	(5)	(1)	(7)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(43)	(4)	—	—	—
’25	(5)	2	3	(9)	(9)
’24	(9)	(2)	(5)	(10)	(26)
’23	(2)	(2)	2	(4)	(6)
’22	(6)	(8)	(1)	(12)	(27)
’21	1	1	(16)	(25)	(39)
’20	(4)	2	(8)	12	2

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(2.39)	(0.52)	—	—	—
’25	(0.77)	(0.16)	(1.56)	(1.72)	(4.22)
’24	2.16	(0.86)	(0.98)	(0.38)	(0.54)
’23	2.76	(2.11)	(2.79)	(2.17)	(3.85)
’22	(2.81)	(1.34)	(2.34)	(2.79)	(9.27)
’21	18.80	23.49	17.48	(14.48)	37.92
’20	(23.84)	(6.30)	(104.95)	(9.99)	(144.08)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	189.75	174.00	93.45	44.70	6.75	11.48	11.25	6.00	8.65	19.34	Analyst estimates 2026–2028 Powerpack
	High	312.75	264.90	213.60	123.75	51.15	58.94	36.47	15.99	34.26	33.50
People
People	Employees	7,658	7,426	7,549	6,600	3,416	3,509	3,497	3,955	5,063	5,140
	Revenue/emp, $m	0.06	0.06	0.06	0.07	0.11	0.07	0.07	0.06	0.06	0.07
Income, $m
Income, $m	Revenue	447	467	460	447	384	235	238	255	304	381
	Gross margin, %	38.79	37.76	35.30	30.54	33.67	33.00	28.02	30.55	33.62	33.56
	EBT	(28)	(42)	(55)	(36)	(295)	126	(54)	(21)	(3)	(72)
	EBT margin, %	(6.16)	(8.92)	(12.04)	(7.96)	(76.84)	53.76	(22.78)	(8.17)	(1.00)	(18.93)
	Net income	(28)	(44)	(54)	(36)	(295)	126	(54)	(21)	(3)	(72)
	Depreciation	62	67	63	66	62	39	40	41	46	58
Per share, $
Per share, $	Revenue	232.05	237.72	231.51	221.78	187.25	85.35	37.50	37.62	21.57	21.07
	Earnings	(14.54)	(22.49)	(26.99)	(17.84)	(144.08)	38.24	(9.27)	(3.85)	(0.54)	(4.22)
	Cash flow	27.11	28.30	18.56	2.59	(3.31)	(10.47)	(0.41)	1.57	(0.13)	1.35
	Capex	(32.31)	(20.33)	(11.03)	23.70	4.15	(3.80)	(3.86)	(2.44)	(1.74)	(1.84)
	Free cash flow	(5.20)	7.97	7.53	26.29	0.84	(14.27)	(4.27)	(0.87)	(1.87)	(0.49)
	Book value	60.64	40.94	17.75	7.13	(136.23)	(17.02)	(16.00)	(16.96)	5.55	0.28
	Shares, m	2	2	2	2	2	3	6	7	14	18
Valuation, ×
Valuation, ×	P/E	0.00	0.00	0.00	0.00	0.00	0.62	0.00	0.00	230.80	0.00
	P/S	1.05	0.89	0.44	0.21	0.07	0.33	0.35	0.24	1.07	1.55
	P/B	4.01	5.15	5.75	6.50	0.00	0.00	0.00	0.00	4.16	117.82
	EV/Sales	3.04	2.98	2.56	2.21	2.37	2.85	3.02	2.63	3.08	3.28
	EV/FCF	(135.61)	88.82	78.72	18.63	529.53	(17.04)	(26.68)	(114.32)	(35.63)	(140.05)
Cash, $m
Cash, $m	Operating cash flow	52	56	37	5	(7)	(29)	(3)	11	(2)	24
	Capex	(62)	(40)	(22)	48	9	(10)	(25)	(17)	(25)	(33)
	Free cash flow	(10)	16	15	53	2	(39)	(27)	(6)	(26)	(9)
Balance, $m
Balance, $m	Working capital	1	(23)	(12)	(66)	(330)	(14)	(51)	(69)	(12)	(27)
	Total debt	938	1,007	1,019	931	909	683	671	629	651	690
	Net debt	891	976	975	894	886	590	640	612	612	659
	Shareholders’ equity	117	80	35	14	(279)	(47)	(102)	(115)	78	5
Returns, %
Returns, %	ROA	(2.59)	(3.79)	(4.60)	(2.98)	(29.98)	15.57	(8.49)	(4.07)	(1.04)	(9.06)
	ROIC	0.89	0.46	0.47	(1.22)	(5.73)	(4.62)	(3.59)	(2.66)	(1.34)	(3.97)
	ROE	(22.18)	(44.76)	(92.65)	(145.15)	223.02	(68.34)	79.41	24.08	41.29	(183.33)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
SGRY Surgery Partners, Inc.	$1.9B	— (loss-making)	— (loss-making)	+2.75% (above 0%: growing)	n/m	−60.63% (below 0%: shrinking)	22.41%	12.78%	Compare
ASTH Astrana Health, Inc.	$1.9B	44.3×	29.7×	+48.52% (above 0%: growing)	+110.53% (above 0%: growing)	−67.74% (below 0%: shrinking)	10.70%	3.53%	Compare
SNDA Sonida Senior Living, Inc.	$1.7B	— (loss-making)	— (loss-making)	+122.02% (above 0%: growing)	n/m	−291.70% (below 0%: shrinking)	34.97%	(2.63%)
ARDT Ardent Health, Inc.	$1.7B	21.7×	7.7×	−1.40% (below 0%: shrinking)	−76.92% (below 0%: shrinking)	+121.70% (above 0%: growing)	100.00%	3.44%	Compare
CMPS COMPASS Pathways PLC Sponsored ADR	$1.6B	— (loss-making)	—	—	n/m	−4.18% (below 0%: shrinking)	—	0.00%	Compare
AMN AMN Healthcare Services Inc	$1.6B	15.0×	31.2×	+2.29% (above 0%: growing)	n/m	−389.43% (below 0%: shrinking)	30.58%	4.00%	Compare
AGL Agilon Health, Inc.	$1.5B	— (loss-making)	— (loss-making)	+7.15% (above 0%: growing)	n/m	−50.19% (below 0%: shrinking)	7.17%	0.79%	Compare
PNTG The Pennant Group, Inc.	$1.5B	44.5×	26.9×	+35.76% (above 0%: growing)	+23.81% (above 0%: growing)	−50.94% (below 0%: shrinking)	14.07%	5.77%	Compare
HCSG Healthcare Services Group, Inc.	$1.5B	12.2×	19.2×	+2.69% (above 0%: growing)	n/m	−26.02% (below 0%: shrinking)	15.89%	4.72%	Compare
Median of peers	$1.6B	21.7×	26.9×	+2.75%	+23.81%	−50.56%	15.89%	3.77%

All 55 Medical Care Facilities stocks →

Sonida Senior Living, Inc. (SNDA) key facts

Strength: Sonida Senior Living, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $381.1 million, up 25.2% from fiscal 2024.
Sonida Senior Living, Inc. (SNDA) is a Medical Care Facilities company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 16, 2026, SNDA traded at $35.29, a market capitalization of $1.7 billion.
Return on equity was −183.3% and debt-to-equity 1.81.
Its Piotroski F-score is 4 out of 9 and its Altman Z-score is −0.14 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.